Free Trial

Virpax Pharmaceuticals (VRPX) SEC Filings & 10K Form

Virpax Pharmaceuticals logo
$0.35 +0.02 (+7.15%)
As of 07/11/2025 03:47 PM Eastern

Recent Virpax Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/03/2025
10:00 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
5:10 AM
Virpax Pharmaceuticals (Filer)
Form S-1/A
03/21/2025
4:20 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 424B4
01/27/2025
11:15 PM
Virpax Pharmaceuticals (Filer)
Form EFFECT
01/15/2025
3:31 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
01/08/2025
3:11 PM
Panis Jaydriane (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2025
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
3:47 PM
Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/30/2024
3:05 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:15 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
4:29 PM
Virpax Pharmaceuticals (Filer)
Form DEF 14A
11/29/2024
5:39 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
4:01 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:31 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
5:06 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
4:20 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
11:15 PM
Virpax Pharmaceuticals (Filer)
Form EFFECT
11/07/2024
4:01 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/28/2024
3:08 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/18/2024
4:28 PM
Virpax Pharmaceuticals (Filer)
Form S-1/A
10/10/2024
4:07 PM
Virpax Pharmaceuticals (Filer)
Form 10-K/A
10/10/2024
4:08 PM
Virpax Pharmaceuticals (Filer)
Form 10-K/A
10/09/2024
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 8-K/A
10/04/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:12 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
8:05 AM
Virpax Pharmaceuticals (Filer)
Form S-1/A
08/13/2024
6:35 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:26 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:30 PM
Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/26/2024
3:31 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
6:45 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
5:40 PM
Su Judy (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/15/2024
7:00 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRPX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners